Association between glycemic traits and melanoma: a mendelian randomization analysis

Area of Science:

• Endocrinology
• Oncology
• Genetics

Background:

• The relationship between glycemic traits and melanoma risk is not well understood.
• Mendelian Randomization (MR) is a valuable tool for investigating potential causal links between exposures and outcomes.

Purpose of the Study:

• To investigate the potential causal relationships between key glycemic traits and melanoma risk using a two-sample MR approach.
• To assess the association between fasting glucose, 2-h glucose, HbA1c, type-2 diabetes, and fasting insulin with melanoma risk.

Main Methods:

• Utilized pooled data from Genome-Wide Association Studies (GWAS) for genetic instrumental variables.
• Employed two-sample Mendelian Randomization (MR) to analyze associations between glycemic traits and melanoma.
• Examined associations using Inverse Variance Weighted (IVW) and MR-Egger regression models.

Main Results:

• Fasting glucose, type-2 diabetes, and HbA1c showed a significant inverse causal association with melanoma risk.
• No significant causal relationship was observed between fasting insulin and melanoma risk.
• A potential causal link between 2-h glucose and melanoma risk was suggested by MR-Egger analysis.

Conclusions:

• Elevated levels of fasting glucose, type-2 diabetes, and HbA1c may be associated with a decreased risk of developing melanoma.
• Fasting insulin does not appear to have a causal effect on melanoma risk.
• Interventions aimed at managing plasma glucose levels could potentially contribute to melanoma prevention strategies.